Hungarian pharma firm Gedeon Richter has signed an exclusive license agreement with Hikma Pharmaceuticals Plc. to sell Richter's anti-psychotic drug ‘cariprazine’ in some Middle Eastern and North African (MENA) markets. Under the terms of the agreement, Richter will be responsible for product supply and Hikma will proceed with the registration and commercialization of the product […]